TRUB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.021000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.953800E-01
Normal-vs-Stage2
2.927200E-01
Normal-vs-Stage3
2.160500E-02
Normal-vs-Stage4
9.230200E-01
Stage1-vs-Stage2
4.895800E-02
Stage1-vs-Stage3
5.129500E-02
Stage1-vs-Stage4
9.173800E-01
Stage2-vs-Stage3
1.133600E-01
Stage2-vs-Stage4
4.946600E-01
Stage3-vs-Stage4
1.671810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.790400E-01
Normal-vs-AfricanAmerican
9.196000E-01
Normal-vs-Asian
3.371200E-01
Caucasian-vs-AfricanAmerican
2.859000E-01
Caucasian-vs-Asian
6.481800E-01
AfricanAmerican-vs-Asian
2.870400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.673000E-01
Normal-vs-Female
4.676400E-01
Male-vs-Female
5.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.053400E-01
Normal-vs-Age(41-60Yrs)
7.793600E-01
Normal-vs-Age(61-80Yrs)
2.622600E-01
Normal-vs-Age(81-100Yrs)
2.927400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.441800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.055200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.077400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.202900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.848190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.992200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.371600E-01
Normal-vs-Daily Drinker
2.259800E-01
Normal-vs-Weekly Drinker
8.952400E-02
Normal-vs-Occasional Drinker
9.239600E-01
Normal-vs-Social Drinker
6.317400E-01
Non Drinker-vs-Daily Drinker
6.459800E-01
Non Drinker-vs-Weekly Drinker
4.907000E-01
Non Drinker-vs-Occasional Drinker
5.650200E-02
Non Drinker-vs-Social Drinker
3.241400E-01
Daily Drinker-vs-Weekly Drinker
8.340000E-01
Daily Drinker-vs-Occasional Drinker
3.138300E-02
Daily Drinker-vs-Social Drinker
2.329200E-01
Weekly Drinker-vs-Occasional Drinker
2.246200E-02
Weekly Drinker-vs-Social Drinker
1.705830E-01
Occasional Drinker-vs-Social Drinker
3.592800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.763600E-02
Normal-vs-Grade 2
2.293800E-02
Normal-vs-Grade 3
4.028200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.702000E-01
Grade 1-vs-Grade 3
8.596800E-01
Grade 1-vs-Grade 4
9.763600E-02
Grade 2-vs-Grade 3
6.127200E-01
Grade 2-vs-Grade 4
2.293800E-02
Grade 3-vs-Grade 4
4.028200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.867840E-01
Normal-vs-NonDiabetic
3.399200E-01
Diabetic-vs-NonDiabetic
2.564200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.070200E-02
Normal-vs-NoPancreatitis
3.591200E-01
Pancreatitis-vs-NoPancreatitis
1.794210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.613200E-01
Normal-vs-N1
3.182800E-01
N0-vs-N1
4.968200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.134200E-01
Normal-vs-TP53-NonMutant
8.118600E-01
TP53-Mutant-vs-TP53-NonMutant
7.120800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
